Acasti Pharma sees cash runway into 2Q26
PremiumThe FlyAcasti Pharma sees cash runway into 2Q26
3M ago
Acasti Pharma reports Q1 EPS (24c) vs. (54c) last year
Premium
The Fly
Acasti Pharma reports Q1 EPS (24c) vs. (54c) last year
3M ago
Acasti Pharma achieves 50% enrollment in STRIVE-ON safety trial
Premium
The Fly
Acasti Pharma achieves 50% enrollment in STRIVE-ON safety trial
4M ago
Acasti Pharma reports Q3 EPS (21c) vs (52c) last year
PremiumThe FlyAcasti Pharma reports Q3 EPS (21c) vs (52c) last year
9M ago
Is ACST a Buy, Before Earnings?
Premium
Pre-Earnings
Is ACST a Buy, Before Earnings?
9M ago
Craig-Hallum starts ‘wrongly cast out’ Acasti Pharma with a Buy
Premium
The Fly
Craig-Hallum starts ‘wrongly cast out’ Acasti Pharma with a Buy
9M ago
Acasti Pharma doses first patient in GTX-104 STRIVE-ON trial
PremiumThe FlyAcasti Pharma doses first patient in GTX-104 STRIVE-ON trial
1y ago
Acasti Pharma files to sell 6.59M common shares for holders
Premium
The Fly
Acasti Pharma files to sell 6.59M common shares for holders
1y ago
Acasti Pharma to host KOL event on GTX-104
Premium
The Fly
Acasti Pharma to host KOL event on GTX-104
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100